CDI Labs
Ian Buell is currently serving as the Vice President of Global Sales at CDI Labs. Prior to this, Ian held various sales positions at NanoString Technologies, Inc., Eppendorf North America, Roche, and Genome Therapeutics Corporation. Ian's career has been focused on technical sales in the life science market, where Ian has excelled in managing territories, supporting account managers, and selling high-end instrumentation systems. Ian holds a Bachelor's degree in Biology-Microbiology from the University of New Hampshire.
CDI Labs
The Seromics Company - We believe that future discoveries depend on a deeper understanding of individual proteins. We’ve combined our vast proteomic libraries with a deep expertise in synthetic biology to create an extensive collection of products and services serving the following areas of science. Our industry-leading HuProt™ array consists of >21,000 unique human proteins, isoform variants, and protein fragments that cover 16,794 unique genes. • Human autoantibody seromics discovery • Protein-protein interactions • Target ID of unknown binders • Antibody specificity Now introducing PhIP-Seq – with MouseScan™ and HuScan™ phage display libraries. At CDI Labs, we believe that partnering with both companies and academic scientists is the path to mutual success. Join us in creating the antigen-specific revolution, and help unravel some of the greatest mysteries in human health.